EFFECT OF IMMUNE MODULATION ON IMMUNOGENIC AND PROTECTIVE ACTIVITY OF A LIVE PLAGUE VACCINE


Cite item

Full Text

Abstract

Aim. Comparative evaluation of the effect of polyoxidonium and betaleukin on immunogenic and protective activity of a live plague vaccine in model animal experiments. Materials and methods. Plague vaccine EV, polyoxidonium, betaleukin, erythrocytic antigenic diagnosticum for determination of F1 antibodies and immune reagents for detection of lymphocytes with F1 receptors (LFR) in adhesive test developed by the authors were used. The experiments were carried out in 12 rabbits and 169 guinea pigs. Results. Immune modulation accelerated the appearance and disappearance of LFR (early phase) and ensured a more rapid and intensive antibody formation (effector phase). Activation by betaleukin is more pronounced than by polyoxidonium. The more rapid and intensive was the development of early phase, the more effective was antibody response to the vaccine. Immune modulation in the experiment with guinea pigs significantly increased protective activity of the vaccine. Conclusion. The use of immune modulators increased immunogenic (in both early and effector phases of antigen-specific response) and protective activity of the EV vaccine. A connection between the acceleration of the first phase of antigen-specific response and general intensity of effector phase of immune response to the EV vaccine was detected.

About the authors

V. V Karalnik

Scientific Centre of Hygiene and Epidemiology, Almaty, Kazakhstan

T. S Ponomareva

Kazakh Scientific Centre of Quarantine and Zoonosis Infections, Almaty, Kazakhstan

P. N Deryabin

Kazakh Scientific Centre of Quarantine and Zoonosis Infections, Almaty, Kazakhstan

T. G Denisova

Scientific Centre of Hygiene and Epidemiology, Almaty, Kazakhstan

N. N Melnikova

Kazakh Scientific Centre of Quarantine and Zoonosis Infections, Almaty, Kazakhstan

T. I Tugambaev

Kazakh Scientific Centre of Quarantine and Zoonosis Infections, Almaty, Kazakhstan

B. B Atshabar

Kazakh Scientific Centre of Quarantine and Zoonosis Infections, Almaty, Kazakhstan

S. B Zakaryan

Kazakh Scientific Centre of Quarantine and Zoonosis Infections, Almaty, Kazakhstan

References

  1. Авдеева Ж.И., Акользина С.Е., Алпатова Н.А.и др. Влияние цитокинов на иммуногенные свойства вакцины против клещевого энцефалита. Цитокины и воспаление. 2009, 8 (2): 16 21.
  2. Каральник Б.В., Дерябин П.Н., Денисова Т.Г. и др. Антигенсвязывающие лимфоциты в динамике иммунного ответа на бактериальные, вирусные и аутоантигены. Известия МОН РК, НАН РК, серия биол. и мед. 2001, 5: 37-43.
  3. Каральник Б.В., Лещинская Л.Ц. Способ получения иммунореагента. АС СССР, 862919. Бюл. изобр. 1981, № 34, с.30.
  4. Караулов А.В., Евсегнееев И.В. Современные подходы к вакцинопрофилактике гриппа. Вакцинация. 2011, 1 (1): 43-52.
  5. Некрасов А.В., Пучкова Н.Г. Стратегия совершенствования и методы оценки гриппозных вакцин. Гриппол® плюс - современная защита от гриппа. Русский медицинский журнал. 2008,16 (23): 1-4.
  6. Петров Р.В., Хаитов Р.М. Иммуногены и вакцины нового поколения. М., 2011.
  7. Симбирцев А.С., Петров А.В., Пигарева Н.В. и др. Новые возможности применения рекомбинантных цитокинов в качестве адъювантов при вакцинации. Биопрепараты. 2011, 1 (41): 16-20.
  8. Хаитов Р.М., Пинегин Б.В. Полиоксидоний: новые аспекты применения. Новые лекарства. 2003, 3: 21.
  9. Шамардин В.А., Каральник Б.В. Сенсибилизация эритроцитов иммуноглобулинами. Методические рекомендации. Алма-Ата, 1981.
  10. Baker E.E., Sommer Н., Foster L. et al. Studies on immunization against plague. 1. The isolation and characterization of the soluble antigen of Pasteurella pestis. J. Immunol. 1952, 68 (2): 131145.
  11. Explanatory note on immunomodulators for the guideline on adjuvants in vaccines for human use// EMEA. Evaluation of Medicines for Human Use. Doc. Ref. EMEA/CHMP/VWP/244894/2006.
  12. Inglesby XV., Dennis D. T., Henderson D.A. et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. 2000, 283: 22812290.
  13. Kindrachuk J., Jensen H., Elliot M. et al. Manipulation of innate immunity by a bacterial secreted peptide: Lantibiotic nisin Z is selectively immunomodulatory. Innate Immunity. 2013, 19: 315327.
  14. Nicholls E.F., Madera L., Hancock R.E.W Immunomodulators as adjuvants for vaccines and antimicrobial therapy. Ann. N.Y. Academy Sci, 2010, 1213: 46-61.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Karalnik V.V., Ponomareva T.S., Deryabin P.N., Denisova T.G., Melnikova N.N., Tugambaev T.I., Atshabar B.B., Zakaryan S.B.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies